MarketPeel
Insider Trading Intelligence
Pricing
…
CB

Clinton Bybee

BEAM
10% OWNER · BEAM THERAPEUTICS INC. · CIK 0001219043
FILING MIX · LIFETIME53%/47%
BUYS
100
SELLS
90
TOTAL VALUE
$58.26M
COMPANIES
9
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
27,078,240
AVG SELL PX
$2.49
TRADE KIND
SHOWING 190 / 190
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Clinton Bybee, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-5.39%-1.50%-3.89%-3.89%—
14d1+0.00%-14.87%-3.54%-11.33%-11.33%—
30d1+0.00%-3.43%-2.00%-1.43%-1.43%—
60d1+0.00%-8.19%+7.64%-15.84%-15.84%—
90d1+0.00%-23.64%————
180d1(1 pending)——————
1y1(1 pending)——————
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BEAM · 2,921,520 shares · as of Jun 30, 2021
01,030,3802,060,7603,091,1404,121,5202021SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 100 buys / 90 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BOLD
BOUNDLESS BIO, INC.
SALE
16,000$2.49$39.8K0Jul 1, 2026Jul 6, 2026 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
16,000——0Jul 1, 2026Jul 6, 2026 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
16,000$1.03$16.5K16,000Jul 1, 2026Jul 6, 2026 ↗View →
LYEL
LYELL IMMUNOPHARMA, INC.
PURCHASE
488,090$25.61$12.50M1,426,528Mar 6, 2026Mar 9, 2026 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
1,915,700$2.61$5.00M6,046,907Oct 27, 2025Oct 29, 2025 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
787,545——828,570Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
201,465——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
366,301——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
227,920——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
586,080——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
133,333$16.00$2.13M1,181,766Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
164,835——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
424,908——0Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
66,667$16.00$1.07M683,759Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
589,743——617,092Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
PURCHASE
1,048,433——1,048,433Apr 2, 2024Apr 4, 2024 ↗View →
BOLD
BOUNDLESS BIO, INC.
SALE
454,212——0Apr 2, 2024Apr 4, 2024 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASE
727,272$5.50$4.00M12,446,022Feb 8, 2024Feb 12, 2024 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASE
363,637$5.50$2.00M10,667,387Feb 8, 2024Feb 12, 2024 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
703,061——1,387,228Dec 8, 2023Dec 12, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
1,176,593——2,321,566Dec 8, 2023Dec 12, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
684,167——684,167Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
1,144,973——1,144,973Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
6,576,400——0Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
6,576,400——11,886,758Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
6,895,021——0Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
1,500,000$17.00$25.50M3,624,143Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
684,167——0Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
2,124,143——0Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
6,895,021——12,205,379Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
PURCHASE
2,124,143——2,124,143Sep 19, 2023Sep 19, 2023 ↗View →
NMRA
NEUMORA THERAPEUTICS, INC.
SALE
1,144,973——0Sep 19, 2023Sep 19, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
3,248——61,160Sep 6, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
310,441——7,290,655Sep 6, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,624——30,570Sep 6, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
239,559——5,626,008Sep 6, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
14,383——272,964Sep 6, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,338——28,946Sep 2, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
253,997——7,601,096Sep 2, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
196,003——5,865,567Sep 2, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,662——57,912Sep 2, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
11,763——258,581Sep 2, 2022Sep 7, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——246,818Aug 31, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——6,061,570Aug 31, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——55,250Aug 31, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——27,608Aug 31, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——7,855,093Aug 31, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——8,137,312Aug 30, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——6,279,351Aug 30, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——233,742Aug 30, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——52,298Aug 30, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——26,133Aug 30, 2022Sep 1, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——8,419,531Aug 25, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——49,346Aug 25, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——6,497,132Aug 25, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——24,658Aug 25, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——220,666Aug 25, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——23,183Aug 24, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——46,394Aug 24, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——6,714,913Aug 24, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——8,701,750Aug 24, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——207,590Aug 24, 2022Aug 26, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——8,983,969Aug 18, 2022Aug 22, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——6,932,694Aug 18, 2022Aug 22, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——43,442Aug 18, 2022Aug 22, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——194,514Aug 18, 2022Aug 22, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——21,708Aug 18, 2022Aug 22, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——20,233Aug 16, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——40,490Aug 16, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——9,266,188Aug 16, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——7,150,475Aug 16, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——181,438Aug 16, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——9,548,407Aug 15, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——7,368,256Aug 15, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——168,362Aug 15, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——18,758Aug 15, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——37,538Aug 15, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——9,830,626Aug 12, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——155,286Aug 12, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——34,586Aug 12, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——7,586,037Aug 12, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——17,283Aug 12, 2022Aug 16, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——7,803,818Jun 8, 2022Jun 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——10,112,845Jun 8, 2022Jun 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,475——15,808Jun 8, 2022Jun 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——142,210Jun 8, 2022Jun 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,952——31,634Jun 8, 2022Jun 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,076——129,134Jun 2, 2022Jun 6, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
4,426——43,015Jun 2, 2022Jun 6, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——10,395,064Jun 2, 2022Jun 6, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——8,021,599Jun 2, 2022Jun 6, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
15,504——38,589Dec 20, 2021Dec 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
45,703——116,058Dec 20, 2021Dec 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
987,767——10,677,283Dec 20, 2021Dec 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
762,233——8,239,380Dec 20, 2021Dec 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,057——70,355Nov 29, 2021Dec 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——11,665,050Nov 29, 2021Dec 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
4,428——23,085Nov 29, 2021Dec 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——9,001,613Nov 29, 2021Dec 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
4,428——18,657Nov 22, 2021Nov 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——9,219,394Nov 22, 2021Nov 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——11,947,269Nov 22, 2021Nov 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
13,057——57,298Nov 22, 2021Nov 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
25,279——44,241Jul 1, 2021Jul 6, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
2,257,752——12,229,488Jul 1, 2021Jul 6, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
8,133——14,229Jul 1, 2021Jul 6, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
1,742,248——9,437,175Jul 1, 2021Jul 6, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
811——4,867Jun 30, 2021Jul 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,555——15,328Jun 30, 2021Jul 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——2,921,519Jun 30, 2021Jul 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
4,686——28,111Jun 30, 2021Jul 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——2,921,520Jun 30, 2021Jul 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,121,520Jun 29, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,121,519Jun 29, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,555——12,773Jun 29, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
811——4,056Jun 29, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
4,686——23,425Jun 29, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,321,519Jun 25, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,321,520Jun 25, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,555——10,218Jun 25, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
4,686——18,739Jun 25, 2021Jun 29, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
811——3,245Jun 25, 2021Jun 29, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
6,320——18,962Jun 22, 2021Jun 24, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
435,562——11,179,423Jun 22, 2021Jun 24, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
2,028——6,096Jun 22, 2021Jun 24, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
564,438——14,487,240Jun 22, 2021Jun 24, 2021 ↗View →
LYEL
LYELL IMMUNOPHARMA, INC.
SALE
435,142——0Jun 21, 2021Jun 21, 2021 ↗View →
LYEL
LYELL IMMUNOPHARMA, INC.
PURCHASE
18,206,358——18,206,358Jun 21, 2021Jun 21, 2021 ↗View →
LYEL
LYELL IMMUNOPHARMA, INC.
SALE
435,142——0Jun 21, 2021Jun 21, 2021 ↗View →
LYEL
LYELL IMMUNOPHARMA, INC.
SALE
17,771,216——0Jun 21, 2021Jun 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
3,161——12,642Apr 8, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——15,051,678Apr 8, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,019——4,068Apr 8, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——11,614,985Apr 8, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——11,832,766Apr 7, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,019——3,049Apr 7, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
3,161——9,481Apr 7, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——15,333,897Apr 7, 2021Apr 9, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——15,616,116Apr 1, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
3,160——6,320Apr 1, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——12,050,547Apr 1, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,016——2,030Apr 1, 2021Apr 1, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
811——2,434Mar 31, 2021Apr 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,555——7,663Mar 31, 2021Apr 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,521,519Mar 31, 2021Apr 2, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,521,520Mar 31, 2021Apr 2, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
1,014——1,014Mar 30, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
217,781——12,268,328Mar 30, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
282,219——15,898,335Mar 30, 2021Apr 1, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
3,160——3,160Mar 30, 2021Apr 1, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,721,520Mar 22, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
813——1,623Mar 22, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,555——5,108Mar 22, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,721,519Mar 22, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
2,553——2,553Mar 18, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,921,520Mar 18, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
200,000——3,921,519Mar 18, 2021Mar 22, 2021 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
810——810Mar 18, 2021Mar 22, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
SALE
5,687,500——0Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
SALE
781,250——0Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
SALE
9,375,000——0Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASE
11,718,750——11,718,750Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
SALE
3,687,500——0Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASE
10,156,250——10,303,750Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASE
10,156,250——10,301,250Feb 8, 2021Feb 10, 2021 ↗View →
SANA
SANA BIOTECHNOLOGY, INC.
SALE
2,343,750——0Feb 8, 2021Feb 10, 2021 ↗View →
MASS
908 DEVICES INC.
SALE
665,661——0Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
SALE
2,927,386——0Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
SALE
180,578——0Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
PURCHASE
5,425,045——5,425,045Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
SALE
981,443——0Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
SALE
669,977——0Dec 22, 2020Dec 22, 2020 ↗View →
MASS
908 DEVICES INC.
PURCHASE
300,000$20.00$6.00M5,725,045Dec 22, 2020Dec 22, 2020 ↗View →
QTRX
QUANTERIX CORP
SALE
176,920——1,214,770Nov 24, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
PURCHASE
1,034——1,888Nov 24, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
SALE
277,514——1,905,481Nov 24, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
PURCHASE
1,036——1,889Nov 24, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
PURCHASE
854——854Nov 20, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
SALE
145,994——1,391,690Nov 20, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
PURCHASE
853——853Nov 20, 2020Nov 24, 2020 ↗View →
QTRX
QUANTERIX CORP
SALE
229,006——2,182,995Nov 20, 2020Nov 24, 2020 ↗View →
PI
IMPINJ INC
PURCHASE
3,411——17,125Oct 23, 2020Oct 23, 2020 ↗View →
PI
IMPINJ INC
SALE
3,411——0Oct 23, 2020Oct 23, 2020 ↗View →
PI
IMPINJ INC
PURCHASEGRANT
Stock grant
2,849——2,849Jun 10, 2020Jun 12, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
4,121,519——4,121,519Feb 10, 2020Feb 11, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
2,750,336——0Feb 10, 2020Feb 11, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
4,121,520——4,121,520Feb 10, 2020Feb 11, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
2,750,335——0Feb 10, 2020Feb 11, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
1,338,000——0Feb 10, 2020Feb 11, 2020 ↗View →
BEAM
BEAM THERAPEUTICS INC.
SALE
33,184——0Feb 10, 2020Feb 11, 2020 ↗View →
Other insiders · BEAM
Loading peer insiders…
About this filer
CIK 0001219043
ROLE
10% Owner
PRIMARY
BEAM
COMPANIES
9
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001219043DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback